AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Discover practical ways to avoid falling into budget traps through smart checks that reinforce your plan and improve long-term financial health.
27,485 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
The FDA approved bemotrizinol for over-the-counter sunscreen use on June 9, 2026, introducing the first new ingredien...
AbbVie stock jumped today after the company disclosed a bold acquisition of Apogee Therapeutics for $10.9 billion. Th...
Finance of America named three senior executives to steer brand, communications and product as it scales retirement-f...
Pump.fun has unveiled a record-setting compensation package for its Chief Legal Officer, signaling a competitive push...
delek holdings rallied today captured market attention as a mid-cap refiner with jet-fuel exposure and a strategic st...
Tanger Outlets, a leading retail REIT, reports a rebound in shopper traffic and demand across its outlet centers in e...
A 10% move in Vericel stock drew attention after a COO sold shares worth $402,000. This article breaks down what the ...
After four days of tit-for-tat strikes, both sides signaled a pause in the Strait of Hormuz. Markets priced in a mana...
Europe endures a blistering heatwave as the U.S. relies on widespread air conditioning. A climate tech executive outl...
A durable industrial leader with long-term contracts stands out as markets tilt toward defensives. Here’s why this in...
Micron Technology has logged an extraordinary 800% rally over the past year, but fresh analysis flags headwinds that ...